Last updated: June 10, 2022
Sponsor: University Hospital, Angers
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Amyotrophic Lateral Sclerosis (Als)
Myasthenia Gravis (Chronic Weakness)
Scar Tissue
Treatment
N/AClinical Study ID
NCT05409508
2022-A01230-43
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Majors to inclusion
- Mother tongue: French
- Patients for whom ALS of bulbar or spinal form defined according to El Escorialcriteria is possible, probable or certain
- Able to carry out the investigations and interventions provided for in the protocol
- Signature of informed consent to participate in the study
Exclusion
Exclusion Criteria:
- Participation in intervention research modifying management
- History likely to disrupt cognition (constituted stroke, sequelae of traumatic braininjury, active epilepsy, learning disabilities, alcohol dependence syndrome, drug use,psychiatric disorders), severe cognitive impairment (MMSE <24)
- People who meet the diagnostic criteria for Frontotemporal Dementia
- Pregnant or lactating women
- Persons deprived of their liberty by administrative or judicial decision
- Persons undergoing psychiatric care under duress
- Persons subject to a legal protection measure
- Persons unable to express their consent
- Persons not affiliated or not beneficiaries of a social security scheme
Study Design
Total Participants: 46
Study Start date:
September 01, 2022
Estimated Completion Date:
June 30, 2023